Company intelligence / Profile preview

Everest Detection

Miami, Florida, United Stateseverestdetection.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Everest Detection is developing innovative molecular diagnostic tests for the early detection of cancer. The company leverages advanced technologies such as next-generation sequencing and single-cell analysis to identify cancers at their earliest stages. No clinical results have been published or reported to date; the company appears to be in preclinical development.

Therapeutic areas: Oncology
Modalities: DeviceMolecular diagnostics (including nucleotide sequencing, single cell detection, microRNA, proteomics)
Industry: Molecular Diagnostics

Partnerships

Partnered with leading oncology clinicians and possibly academic collaborators for assay development and validation. Specific partners are not named publicly.

Beyond the preview

Go deeper on Everest Detection.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Everest Detection.

Explore the full profile